Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received December 27, 2021
- Revision received January 20, 2022
- Accepted January 26, 2022
- Published online February 26, 2022.
Copyright & Usage
Copyright © 2022 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.
Author Information
- TAKURO OKADA1⇑,
- CHIHIRO FUSHIMI2,
- TAKASHI MATSUKI3,
- ISAKU OKAMOTO1,
- HIROKI SATO1,
- TAKAHITO KONDO4,
- KUNIHIKO TOKASHIKI1,
- TAKUMA KISHIDA1,
- TATSUYA ITO1,
- GAI YAMASHITA1,
- YUSUKE AIHARA4,
- KENJI HANYU2,
- YUKIOMI KUSHIHASHI2,
- TATSUO MASUBUCHI2,
- YUICHIRO TADA2,
- KOUKI MIURA2,
- YUKI HARADA3,
- KAHO MOMIYAMA3,
- TAKU YAMASHITA3,
- GO OMURA5,
- HIDEAKI TAKAHASHI6,
- NOBUHIKO ORIDATE6 and
- KIYOAKI TSUKAHARA1
- 1Department of Otorhinolaryngology, Head and Neck Surgery, Tokyo Medical University, Tokyo, Japan
- 2Department of Head and Neck Oncology and Surgery, International University of Health and Welfare Mita Hospital, Tokyo, Japan
- 3Department of Otorhinolaryngology, Head and Neck Surgery, Kitasato University School of Medicine, Sagamihara, Japan
- 4Department of Otorhinolaryngology, Head and Neck Surgery, Tokyo Medical University Hachioji Medical Center, Tokyo, Japan
- 5Department of Head and Neck Oncology, National Cancer Center Hospital, Tokyo, Japan
- 6Department of Otorhinolaryngology, Head and Neck Surgery, Yokohama City University, Yokohama, Japan
- Correspondence to: Takuro Okada, Department of Otorhinolaryngology, Head and Neck Surgery, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo 160-0023, Japan. Tel: +81 333426111, Fax: +81 333426203, e-mail: takuhns{at}tokyo-med.ac.jp
In this issue
Comparison of Dosage of Nivolumab in Efficacy and Safety for Recurrent Metastatic Squamous Cell Carcinoma
Jump to section
Related Articles
Cited By...
- No citing articles found.